Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gobert

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1993
Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonistsM J Millan, J M Rivet, H Canton, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1994
5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigmM J Millan, J M Rivet, A Gobert, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2000
Induction of spontaneous tail-flicks in rats by blockade of transmission at N-methyl-D-aspartate receptors: roles of multiple monoaminergic receptors in relation to the actions of antipsychotic agentsM J Millan, A Gobert, K Bervoets, et al.
European Journal of Pharmacology|July 21, 1994
Clozapine inhibits serotoninergic transmission by an action at alpha 1-adrenoceptors not at 5-HT1A receptorsF Lejeune, V Audinot, A Gobert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2015
EGFR-independent mechanisms of acquired resistance to AZD9291 in EGFR T790M-positive NSCLC patientsD Planchard, Y Loriot, F André, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1995
Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in ratsA Gobert, F Lejeune, J M Rivet, et al.
Neuroscience|April 16, 1998
Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of releaseA Gobert, J M Rivet, V Audinot, et al.
The Journal of Clinical Investigation|October 1, 1985
A distant gene deletion affects beta-globin gene function in an atypical gamma delta beta-thalassemiaP Curtin, M Pirastu, Y W Kan, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
Multiple alpha-2 adrenergic receptor subtypes. II. Evidence for a role of rat R alpha-2A adrenergic receptors in the control of nociception, motor behavior and hippocampal synthesis of noradrenalineM J Millan, K Bervoets, J M Rivet, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2001
S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramineM J Millan, A Gobert, F Lejeune, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1993
Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonistsM J Millan, J M Rivet, H Canton, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1994
5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigmM J Millan, J M Rivet, A Gobert, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2000
Induction of spontaneous tail-flicks in rats by blockade of transmission at N-methyl-D-aspartate receptors: roles of multiple monoaminergic receptors in relation to the actions of antipsychotic agentsM J Millan, A Gobert, K Bervoets, et al.
European Journal of Pharmacology|July 21, 1994
Clozapine inhibits serotoninergic transmission by an action at alpha 1-adrenoceptors not at 5-HT1A receptorsF Lejeune, V Audinot, A Gobert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2015
EGFR-independent mechanisms of acquired resistance to AZD9291 in EGFR T790M-positive NSCLC patientsD Planchard, Y Loriot, F André, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1995
Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in ratsA Gobert, F Lejeune, J M Rivet, et al.
Neuroscience|April 16, 1998
Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of releaseA Gobert, J M Rivet, V Audinot, et al.
The Journal of Clinical Investigation|October 1, 1985
A distant gene deletion affects beta-globin gene function in an atypical gamma delta beta-thalassemiaP Curtin, M Pirastu, Y W Kan, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
Multiple alpha-2 adrenergic receptor subtypes. II. Evidence for a role of rat R alpha-2A adrenergic receptors in the control of nociception, motor behavior and hippocampal synthesis of noradrenalineM J Millan, K Bervoets, J M Rivet, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2001
S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramineM J Millan, A Gobert, F Lejeune, et al.
Pageof 8